Our investment approach
is one of active involvement
growth and strategy.

Who We Are

Fred Eshelman is the founder of Eshelman Ventures LLC, an investment company primarily interested in healthcare companies. He usually serves on the boards of portfolio companies. Previously he founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests.

Learn More

06.13.2018

Fount Therapeutics, LLC is a sustainable drug discovery enterprise with a proven team of R & D talent that has created multiple launched medicines. Fount is maturing three newco subsidiaries: Kinnate Biopharma, Inc. (Oncology), Immanate Therapeutics, Inc. (Immunology & Immuno-Oncology), and Audere Medicines, Inc.... Continue